Potential Application Value of Contrast-Enhanced Ultrasound In Neoadjuvant Chemotherapy of Breast Cancer

Ultrasound in Medicine and Biology

Volumn 38, Issue 12, 2012, Pages 2065-2071

  Cao, Xiaoli ^a,b   Xue, Jie ^b   Zhao, Bin ^a  

^a SHANDONG UNIVERSITY   (China)

^b YANTAI YUHUANGDING HOSPITAL   (China)

Author keywords

Breast cancer; Doppler ultrasound; Neoadjuvant chemotherapy; Ultrasound contrast media

Indexed keywords

BLOOD PERFUSION; BREAST CANCER; CONTRAST ENHANCED ULTRASOUND; DOPPLER ULTRASOUND; PEAK INTENSITY; POTENTIAL APPLICATIONS; TIME TO PEAK; TIME-INTENSITY CURVES; TUMOR SIZE; ULTRASOUND CONTRAST;

BLOOD; CHEMOTHERAPY; CONTRAST MEDIA; PATIENT TREATMENT; TUMORS; ULTRASONICS;

DISEASES;

DOCETAXEL; EPIRUBICIN;

ACCURACY; ADULT; AGED; ARTICLE; BREAST CANCER; BREAST NECROSIS; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; COMPARATIVE EFFECTIVENESS; CONTRAST ENHANCEMENT; CONTROLLED STUDY; ECHOGRAPHY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMAGE DISPLAY; INTERMETHOD COMPARISON; LIQUEFACTION; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TREATMENT RESPONSE; TUMOR VOLUME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CONTRAST MEDIA; EPIRUBICIN; FEMALE; HUMANS; MIDDLE AGED; NEOADJUVANT THERAPY; TAXOIDS; ULTRASONOGRAPHY, DOPPLER, COLOR; ULTRASONOGRAPHY, MAMMARY;

EID: 84870293441     PISSN: 03015629     EISSN: 1879291X     Source Type: Journal    
DOI: 10.1016/j.ultrasmedbio.2012.07.027     Document Type: Article

References (20)

1. Balleyguier C., Opolon P., Mathieu M.C., Athanasiou A., Garbay J.R., Delaloge S., Dromain C. New potential and applications of contrast-enhanced ultrasound of the breast: Own investigations and review of the literature. Eur J Radiol 2009, 69:14-23.
2. Balu-Maestro C., Chapellier C., Bleuse A., Chanalet I., Chauvel C., Largillier R. Imaging in evaluation of response to neoadjuvant breast cancer treatment benefits of MRI. Breast Cancer Res Treat 2002, 72:145-152.
3. Cassano E., Rizzo S., Bozzini A., Menn S., Bellomi M. Contrast-enhanced ultrasound of breast cancer. Cancer Imaging 2006, 6:4-6.
4. Chagpar A.B., Middleton L.P., Sahin A.A., Dempsey P., Buzdar A.U., Mirza A.N., Ames F.C., Babiera G.V., Feig B.W., Hunt K.K., Kuerer H.M., Meric-Bernstam F., Ross M.I., Singletary S.E. Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy. Ann Surg 2006, 243:257-264.
5. Chen A.M., Meric-Bernstam F., Hunt K.K., Thames H.D., Outlaw E.D., Strom E.A., McNeese M.D., Kuerer H.M., Ross M.I., Singletary S.E., Ames F.C., Feig B.W., Sahin A.A., Perkins G.H., Babiera G., Hortobagyi G.N., Buchholz T.A. Breast conservation after neoadjuvant chemotherapy. Cancer 2005, 103:689-695.
6. Chen J.H., Feig B.A., Hsiang J.B., Butler J.A., Mehta R.S., Bahri S., Nalcioglu O., Su M.Y. Impact of MRI-evaluated neoadjuvant chemotherapy response on change of surgical recommendation in breast cancer. Ann Surg 2009, 249:448-454.
7. Eisenhauer E.A., Therasse P., Bogaerts J., Schwartz L.H., Sargent D., Ford R., Dancey J., Arbuck S., Gwyther S., Mooney M., Rubinstein L., Shankar L., Dodd L., Kaplan R., Lacombe D., Verweij J. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer 2009, 45:228-247.
8. Fischer D.R., Baltzer P., Malich A., Wurdinger S., Freesmeyer M.G., Marx C., Kaiser W.A. Is the " blooming sign" a promising additional tool to determine malignancy in MR mammography?. Eur Radiol 2004, 14:394-401.
9. Greis C. Technology overview: SonoVue (Bracco, Milan). Eur Radiol 2004, 14(Suppl 8):11-15.
10. Hayes C., Padhani A.R., Leach M.O. Assessing changes in tumor vascular function using dynamic contrast-enhanced magnetic resonance imaging. NMR Biomed 2002, 15:154-163.
11. Kumar A., Singh S., Pradhan S., Shukla R.C., Ansari M.A., Singh T.B., Shyam R., Gupta S. Doppler ultrasound scoring to predict chemotherapeutic response in advanced breast cancer. World J Surg Oncol 2007, 5:99.
12. Liu H., Jiang Y.X., Liu J.B., Zhu Q.L., Sun Q., Chang X.Y. Contrast-enhanced breast ultrasonography imaging features with histopathologic correlation. Ultrasound Med 2009, 28:911-920.
13. Loo C.E., Teertstra H.J., Rodenhuis S., Van de Vijver M.J., Hannemann J., Muller S.H., Peeters M.J., Gihuijs K.G. Dynamic contrast-enhanced MRI for prediction of breast cancer response to neoadjuvant chemotherapy: initial results. AJR 2008, 191:1331-1338.
14. Padhani A.R., Hayes C., Assersohn L., Powles T., Makris A., Suckling J., Leach M.O., Husband J.E. Prediction of clinicopathologic response of breast cancer to primary chemotherapy at contrast-enhanced MR imaging: initial clinical results. Radiology 2006, 239:361-374.
15. Partridge S.C., Gibbs J.E., Lu Y., Esserman L.J., Sudilovsky D., Hylton N.M. Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy. AJR 2002, 179:1193-1199.
16. Ricci P., Cantisani V., Ballesio L., Pagliara E., Sallusti E., Drudi F.M., Trippa F., Calascibetta F., Erturk S.M., Modesti M., Passariello R. Benign and malignant breast lesions: efficacy of real-time contrast-enhanced ultrasound vs. magnetic resonance imaging. Ultraschall Med 2007, 28:57-62.
17. Rosen E.L., Blackwell K.L., Baker J.A., Soo M.S., Bentley R.C., Yu D., Samulski T.V., Dewhirst M.W. Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy. AJR 2003, 181:1275-1282.
18. Schwartz G. Neoadjuvant induction chemotherapy. Minerva Ginecol 2005, 57:327-348.
19. Stuhrmann M., Schwarz T., Schietzel M. Breast cancer recurrence versus scar: Ultrasonographic differentiation using Levovist as the contrast medium. Ultraschall Med 2001, 22:2-6.
20. Vallone P., D'Angelo R., Filice S., Petrosino T., Rinaldo M., De Chiara A., Gallipoli A. Color Doppler using contrast medium in evaluating the response to neoadjuvant treatment in patients with locally advanced breast carcinoma. Anticancer Res 2005, 25:595-600.